Spyre Therapeutics, Inc. · NASDAQ:SYRE
Perceptive Advisors LLC's stake in Spyre Therapeutics, Inc. fell to 4.90% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Perceptive Advisors LLC's stake in Spyre Therapeutics, Inc. fell to 4.90%, 4,319,496 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 4.90%
- Shares
- 4,319,496
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 4.90% | 4,319,496 |
| Joseph Edelman | 4.90% | 4,319,496 |
| Perceptive Life Sciences Master Fund, Ltd. | 4.90% | 4,319,496 |
Source
Related
- Spyre Therapeutics, Inc.
- Perceptive Advisors LLC
- Spyre Therapeutics, Inc. shareholders
- Schedule 13G · Perceptive Advisors LLC · Apr 22, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Feb 14, 2025
- Schedule 13D/A · Harwin Peter Evan · Oct 9, 2026
- Form 4 · Burrows Scott L · Oct 2, 2026
- Form 4 · King-Jones Heidy · Oct 2, 2026
- Form 4 · Turtle Cameron · Oct 2, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Oct 1, 2026